Bsw Wealth Partners Moderna, Inc. Transaction History

Bsw Wealth Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $355 - $481	-3 Reduced 0.18%	1,677 $203,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $1,085 - $1,576	-8 Reduced 0.47%	1,680 $258,000
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $199,825 - $354,547	1,688 New	1,688 $303,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $33,850 - $51,034	289 Added 21.79%	1,615 $231,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $67,276 - $125,046	532 Added 67.0%	1,326 $228,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $12,420 - $20,268	-55 Reduced 6.48%	794 $202,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $86,541 - $188,943	-390 Reduced 31.48%	849 $327,000
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $160,958 - $291,140	1,239 New	1,239 $291,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Bsw Wealth Partners with notifications on news.